Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07112677) titled 'Seroprevalence of Brucella Antibodies in High-Risk Patients With Low Back Pain: A Case-Control Study' on Aug. 2.

Study Type: Observational

Primary Sponsor: Elham Ahmed Hassan

Condition: Brucellosis Low Back Pain

Intervention: Diagnostic Test: Brucella Antibody Testing (ELISA)

Recruitment Status: Not recruiting

Date of First Enrollment: February 1, 2024

Target Sample Size: 100

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07112677

Published by HT Digital Content Services with permission from Health Daily Digest....